Additional information reported to FDA by drug manufacturers could help the agency anticipate potential drug shortages through the use of predictive algorithms, FDA Administrator Robert Califf told the House Oversight & Accountability Committee. Califf testified Thursday (April 11) that the list of authorities FDA has requested from Congress as part of its fiscal 2025 budget, including more notification requirements for manufacturers, could help “put together predictive algorithms” that would give FDA more insight into the drug supply chain and help...